Tom Tanbo1,2, Gareth Greggains1, Ritsa Storeng3, Bjørn Busund1, Anton Langebrekke1, Peter Fedorcsak1,2. 1. Department of Gynecology, Oslo University Hospital, Oslo, Norway. 2. Institute of Clinical Medicine, University of Oslo, Oslo, Norway. 3. Norwegian National Advisory Unit on Women's Health, Oslo University Hospital, Oslo, Norway.
Abstract
INTRODUCTION: With increasing survival rates after treatment for cancer in prepubertal girls and women of reproductive age, an increasing focus on quality of life has emerged. Both irradiation and cytotoxic drugs can be detrimental to future fertility, consequently several treatment alternatives have been developed to spare or restore fertility in young females diagnosed with cancer. One of these options is cryopreservation of ovarian tissue before treatment and autotransplantation at a later time. MATERIAL AND METHODS: We present the Norwegian experience after 11 years of practice with ovarian tissue cryopreservation. A total of 164 patients have had ovarian tissue cryopreserved during the period 2004-2014. Fifteen patients died during the observation period. Six patients requested autotransplantation, which was performed in two women. RESULTS: Both patients conceived, one spontaneously and one after assisted reproduction due to a concomitant male factor. The pregnancies were uneventful and they each gave birth to a healthy child. CONCLUSIONS: Cryopreservation with later autotransplantation of ovarian tissue should be offered to a selected group of young women with cancer.
INTRODUCTION: With increasing survival rates after treatment for cancer in prepubertal girls and women of reproductive age, an increasing focus on quality of life has emerged. Both irradiation and cytotoxic drugs can be detrimental to future fertility, consequently several treatment alternatives have been developed to spare or restore fertility in young females diagnosed with cancer. One of these options is cryopreservation of ovarian tissue before treatment and autotransplantation at a later time. MATERIAL AND METHODS: We present the Norwegian experience after 11 years of practice with ovarian tissue cryopreservation. A total of 164 patients have had ovarian tissue cryopreserved during the period 2004-2014. Fifteen patients died during the observation period. Six patients requested autotransplantation, which was performed in two women. RESULTS: Both patients conceived, one spontaneously and one after assisted reproduction due to a concomitant male factor. The pregnancies were uneventful and they each gave birth to a healthy child. CONCLUSIONS: Cryopreservation with later autotransplantation of ovarian tissue should be offered to a selected group of young women with cancer.
Authors: M M Dolmans; M M Binda; S Jacobs; J P Dehoux; J L Squifflet; J Ambroise; J Donnez; C A Amorim Journal: J Assist Reprod Genet Date: 2015-08-04 Impact factor: 3.412
Authors: S E Gellert; S E Pors; S G Kristensen; A M Bay-Bjørn; E Ernst; C Yding Andersen Journal: J Assist Reprod Genet Date: 2018-03-01 Impact factor: 3.412
Authors: Triin Tammiste; Keiu Kask; Peeter Padrik; Külli Idla; Karin Rosenstein; Tatjana Jatsenko; Piret Veerus; Andres Salumets Journal: BMC Womens Health Date: 2019-05-14 Impact factor: 2.809
Authors: Federica Tomao; Anna Di Pinto; Carolina Maria Sassu; Erlisa Bardhi; Violante Di Donato; Ludovico Muzii; Maria Cristina Petrella; Fedro Alessandro Peccatori; Pierluigi Benedetti Panici Journal: Ecancermedicalscience Date: 2018-12-06
Authors: Kenny A Rodriguez-Wallberg; Tom Tanbo; Helena Tinkanen; Ann Thurin-Kjellberg; Elizabeth Nedstrand; Margareta Laczna Kitlinski; Kirsten T Macklon; Erik Ernst; Jens Fedder; Aila Tiitinen; Laure Morin-Papunen; Snorri Einarsson; Varpu Jokimaa; Maritta Hippeläinen; Mikael Lood; Johannes Gudmundsson; Jan I Olofsson; Claus Yding Andersen Journal: Acta Obstet Gynecol Scand Date: 2016-07-03 Impact factor: 3.636